Podcast Episodes
Back to SearchThe Complex Decisions in CLL Treatment Today: Clarifying the Choices
Lori Leslie, MD, and Robert Figlin, MD, discuss the latest drugs and clinical trial data on CLL treatment. Dr. Leslie shares her strategy for sequenc…
3 years, 11 months ago
DREAMseq Trial: What It Means for Metastatic Melanoma Treatment
Sapna Patel, MD, Associate Professor at MD Anderson Cancer Center, and Robert Figlin, MD, Deputy Director at Cedars-Sinai Cancer, discuss the clinica…
4 years ago
The Latest Thinking Regarding Adjuvant Pembrolizumab in Renal Cell Carcinoma Post-ASCO GU ‘22
Rana McKay, MD, Allan Pantuck, MD, and Robert Figlin, MD, discuss the recent update to the Keynote-564 study investigating adjuvant pembrolizumab in …
4 years ago